High-flow nasal cannula versus conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia: a multicenter randomized controlled trial

Xia, Jingen; Gu, Sichao; Lei, Wei; Zhang, Jihua; Wei, Hui; Liu, Chao; Zhang, Han; Lu, Rongli; Zhang, Liqiong; Jiang, Mingyan; Hu, Chao; Cheng, Zhenshun; Wei, Chaojie; Chen, Yusheng; Lu, Fengfeng; Chen, Min; Bi, Hong; Liu, Hui; Yan, Cunzi; Teng, Hong; Yang, Yang; Liang, Chen; Ge, Yanlei; Hou, Pengguo; Liu, Jialin; Gao, Weiwei; Zhang, Yi; Feng, Yingying; Tao, Cheng; Huang, Xu; Pan, Pinhua; Luo, Hong; Yun, Chunmei; Zhan, Qingyuan

doi:10.1186/s13054-022-03973-7

Public

High-flow nasal cannula versus conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia: a multicenter randomized controlled trial

Shared by NobleBlocks on Apr 15, 2022 • 12:00 AM UTC

Authors:

Jingen Xia

Sichao Gu

Wei Lei

Abstract

Abstract Background High-flow nasal cannula (HFNC) can improve ventilatory function in patients with acute COPD exacerbation. However, its effect on clinical outcomes remains uncertain. Methods This randomized controlled trial was conducted from July 2017 to December 2020 in 16 tertiary hospitals in...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!